Vibrating pad for apnea in very premature babies
Part of Lungs & breathing clinical trials.
This trial is testing a special vibrating pad (Prapela®) placed in the incubator to see if it can help reduce apnea episodes (pauses in breathing) in very premature babies. It is for babies who are already getting caffeine medicine and need only minimal extra breathing support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 22 weeks 0 days and 32 weeks 6 days of pregnancy.
- Your baby is a single birth (not a twin, triplet, etc.).
- In the last 24 hours, your baby has had at least 4 apnea events (pauses in breathing).
- Your baby is getting caffeine citrate medicine to help with breathing.
- Your baby is not on a ventilator or having extra pressure support for breathing.
- Your baby does not have major birth defects (except a small hernia or patent ductus arteriosus).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether the medicine doxapram can better treat breathing pauses (apnea) in very preterm babies who are already on breathing support in the NICU. It aims to reduce the need for extra interventions and improve outcomes in this high-risk group.
This trial tests whether giving caffeine citrate can help prevent breathing pauses (apnea) in preterm babies who are ready to stop their current caffeine treatment. It aims to see if a short course of caffeine can keep babies stable after they come off oxygen and are eating well.
This trial tests whether caffeine therapy helps keep the heart and blood pressure stable in premature babies being treated for pauses in breathing (apnea of prematurity). Doctors want to see if caffeine is safe and effective for supporting heart function in the NICU.
This study tests a new way to reduce the number of times a preemie baby stops breathing (apnea). It's for babies born early who have apnea but are not on a breathing machine.
This trial tests whether giving caffeine citrate early to very preterm babies (born before 32 weeks) can improve their breathing and overall health. It's for babies who need caffeine anyway as part of their care, and it looks at short- and long-term benefits.
This study uses monitoring to predict when premature infants might stop breathing (apnea) and have a slow heart rate (bradycardia). If your baby was born very early and has had these episodes recently, this study may help doctors anticipate them.
Hear when a new Apnea of Prematurity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.